Viewing Study NCT02806960


Ignite Creation Date: 2025-12-25 @ 2:17 AM
Ignite Modification Date: 2026-03-13 @ 7:08 AM
Study NCT ID: NCT02806960
Status: TERMINATED
Last Update Posted: 2019-12-13
First Post: 2016-05-26
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of Single and Repeated Doses of Glucagon Administered to Participants With Diabetes
Sponsor: Eli Lilly and Company
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2014-06
Start Date Type: None
Primary Completion Date: 2014-06
Primary Completion Date Type: ACTUAL
Completion Date: 2014-08
Completion Date Type: ACTUAL
First Submit Date: 2016-05-26
First Submit QC Date: None
Study First Post Date: 2016-06-21
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2019-08-14
Results First Submit QC Date: None
Results First Post Date: 2019-12-13
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2019-11-25
Last Update Post Date: 2019-12-13
Last Update Post Date Type: ACTUAL